Success Rate Natural Cycles Versus Modified Natural Cycles in Frozen Embryos
NCT ID: NCT03798886
Last Updated: 2019-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-01-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Versus Delayed Natural Cycle Frozen Embryo Transfers
NCT05215119
Does the Embryo Transfer Technique Affect the Success of in Vitro Fertilization?
NCT03756857
The Effect of Embryo Transfer Technique on Pregnancy Outcomes in HRT-FET Cycles
NCT05564312
Natural Cycles With Spontaneous Versus Induced Ovulation in FET
NCT03581422
Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer
NCT02834117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The endometrium in stimulated cycles is not optimal for implantation
2. Pregnancy rates are increased following FET
3. Perinatal outcomes are less affected after FET
4. Preimplantation genetic screening We will follow only natural and modified natural cycles patients. Spontaneous ovulation will documented with hormonal and sonographic monitoring. Hormonal monitoring are including estradiol and luteinizing hormone (LH). Sonographic monitoring is including follicule diameter (16-20 mm). At modified natural cycles we will use hCG triggering for ovulation approximately 16-20 mm diameter.
We will compare success rate between natural and modified natural cycles
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Natural frozen embryo transfer group
In this group all embryos will be frozen when transfer planned sonographic follicle diameter measured. After spontaneous ovulation, embryo transfer will be planned. Luteal phase support will not be used.
natural cycle
When follicle is ready for ovulation, we will use this injection by intra-dermal route
modified natural cycle
we will use that drug in the natural modified transfer group after embryo transfer
embryo transfer
we will do transfer when the endometrium is ready
modified natural embryo transfer group
In this group all embryos will be frozen when transfer planned sonographic follicle diameter measured. When follicle diameter is 16-17 mm we will apply hCG (recombinant hCG). After ovulation, embryo transfer will be done. Luteal phase support will not be used.
natural cycle
When follicle is ready for ovulation, we will use this injection by intra-dermal route
modified natural cycle
we will use that drug in the natural modified transfer group after embryo transfer
embryo transfer
we will do transfer when the endometrium is ready
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
natural cycle
When follicle is ready for ovulation, we will use this injection by intra-dermal route
modified natural cycle
we will use that drug in the natural modified transfer group after embryo transfer
embryo transfer
we will do transfer when the endometrium is ready
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infertile women under 40 years of age who accepted this study.
* Unexplained infertilite couple.
* All ovulatory patient.
* Male factor.
* Tubal factor.
Exclusion Criteria
* Over 40 years of age women.
* Patients with preimplantation genetic diagnosis.
* Anovulatory patient.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Turgut Aydın
Role: STUDY_DIRECTOR
acıbadem university atakent hospital
Elif Ganime Aydeniz
Role: STUDY_CHAIR
acıbadem university atakent hospital
Emine Karabük
Role: STUDY_CHAIR
acıbadem university atakent hospital
Burak Yücel
Role: STUDY_CHAIR
Kanuni Sultan SüleymanHospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acibadem MAA University Atakent Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Weissman A, Horowitz E, Ravhon A, Steinfeld Z, Mutzafi R, Golan A, Levran D. Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen-thawed embryo transfer: a randomized study. Reprod Biomed Online. 2011 Oct;23(4):484-9. doi: 10.1016/j.rbmo.2011.06.004. Epub 2011 Jun 15.
Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update. 2013 Sep-Oct;19(5):458-70. doi: 10.1093/humupd/dmt030. Epub 2013 Jul 2.
Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D'Hooghe T, Castilla JA, Calhaz-Jorge C, De Geyter C, Goossens V; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHREdagger. Hum Reprod. 2014 Oct 10;29(10):2099-113. doi: 10.1093/humrep/deu175. Epub 2014 Jul 27.
Fatemi HM, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P. Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril. 2010 Nov;94(6):2054-8. doi: 10.1016/j.fertnstert.2009.11.036. Epub 2010 Jan 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATADEK-2018/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.